National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. Further, the company offers health risk assessment solutions that enable clients to segment populations and manage care for those who are most at risk, engage individuals, enhance preventative care, and manage wellness programs; and transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, enhance patient satisfaction and support safe care transitions. Additionally, it provides transparency solutions that allow healthcare organizations to share picture of their organization and ensure content informs in consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. The company serves integrated health systems, post-acute providers, and payer organizations. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.
IPO Year:
Exchange: NASDAQ
Website: nrchealth.com
Date | Price Target | Rating | Analyst |
---|
4 - NATIONAL RESEARCH CORP (0000070487) (Issuer)
4 - NATIONAL RESEARCH CORP (0000070487) (Issuer)
4 - NATIONAL RESEARCH CORP (0000070487) (Issuer)
4 - NATIONAL RESEARCH CORP (0000070487) (Issuer)
4 - NATIONAL RESEARCH CORP (0000070487) (Issuer)
3 - NATIONAL RESEARCH CORP (0000070487) (Issuer)
4 - NATIONAL RESEARCH CORP (0000070487) (Issuer)
4 - NATIONAL RESEARCH CORP (0000070487) (Issuer)
3 - NATIONAL RESEARCH CORP (0000070487) (Issuer)
3 - NATIONAL RESEARCH CORP (0000070487) (Issuer)
National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the second quarter 2024 and several other corporate developments. Financial Results Revenue for the quarter was approximately $35 million compared with approximately $36 million in the 2023 quarter. Earnings per diluted share were $0.26 compared with $0.29 for the 2023 quarter. At June 30, 2024, the Company's net indebtedness (total borrowing minus cash and cash equivalents) was approximately $42 million. Total recurring contract value (TRCV) was approximately $138 million at June 30, 2024. Credit Agreement Amendment Effective August 5, 2024, the Company and its lender entered into a Third Amendm
National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the first quarter 2024. CEO Commentary Michael Hays, Chief Executive Officer, commented: "NRC continues to be strongly positioned for growth in our expanding markets. Our decades of benchmarks and trusted thought leadership afford healthcare insights unavailable to most competitors, while our client service remains unmatched, and we continue to roll out innovative new products and technologies. Our mission to enhance outcomes and experiences for everyone in the healthcare journey, while improving our clients' bottom lines, provides true alignment with our clients. "Healthcare systems are facing unp
National Research Corporation (NASDAQ:NRC) today announced that it will provide an online web simulcast of its 2024 first quarter earnings conference call on Wednesday, May 8, 2024. The Company's results for the 2024 first quarter will be released after the close of the market on Tuesday, May 7, 2024. The live broadcast of National Research Corporation's conference call will begin at 11:00 a.m. Eastern Time on May 8, 2024. A 30-day online replay will be available approximately one hour following the conclusion of the live broadcast. A live audio webcast can be accessed at https://events.q4inc.com/attendee/554254445. The webcast will also be available for replay. For more than 40 years
National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the fourth quarter 2023. CEO Commentary Michael Hays, Chief Executive Officer, commented: "We're pleased to start 2024 with momentum from another consecutive quarter of growth in new sales and operating margin. We have trimmed non-core service lines, and developed our capability across the patient, customer, and employee experience continuum to focus on our clients' most important needs. With industry-leading solutions – from C-Suite strategy through The Governance Institute, to customized data benchmarking and analysis, to actionable front-line solutions – NRC is better positioned than ever, and our
National Research Corporation (NASDAQ:NRC) today announced that it will provide an online web simulcast of its 2023 fourth quarter and year-end earnings conference call on Wednesday, February 14, 2024. The Company's results for the 2023 fourth quarter will be released after the close of the market on Tuesday, February 13, 2024. The live broadcast of National Research Corporation's conference call will begin at 11:00 a.m. Eastern Time on February 14, 2024. A 30-day online replay will be available approximately one hour following the conclusion of the live broadcast. A live audio webcast can be accessed at https://events.q4inc.com/attendee/823574505. The webcast will also be available for
Lincoln, Nebraska, Nov. 17, 2023 (GLOBE NEWSWIRE) -- National Research Corporation, dba NRC Health, (NASDAQ:NRC) announced that its Board of Directors has declared a quarterly cash dividend of $0.12 (twelve cents) per share payable Friday, January 12, 2024, to shareholders of record as of the close of business on Friday, December 29, 2023. For more than 40 years, NRC Health (NASDAQ:NRC) has led the charge to humanize healthcare and support organizations in their understanding of each unique individual. NRC Health's commitment to Human Understanding® helps leading healthcare systems get to know each person they serve not as point-in-time insights, but as an ongoing relationship. G
LINCOLN, Neb., Nov. 07, 2023 (GLOBE NEWSWIRE) -- National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the third quarter 2023. Regarding the Company's 2023 third quarter, Kevin Karas, Chief Financial Officer, said, "New sales increased compared to the third quarter of 2022, supported by growth in our Human Understanding Program, with adoption by 91 healthcare organizations as of September 30, 2023. While building our sales pipeline, we are also highly focused on controlling costs in an inflationary environment. We have realized sequential quarterly operating margin improvement in the last two quarters and will continue to emphasize returning to our histor
Lincoln, Nebraska, Oct. 24, 2023 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ/:NRC) today announced that it will provide an online web simulcast of its 2023 third quarter earnings conference call on Wednesday, November 8, 2023. The Company's results for the 2023 third quarter will be released after the close of the market on Tuesday, November 7, 2023. The live broadcast of National Research Corporation's conference call will begin at 11:00 a.m. Eastern Time on November 8, 2023. A 30-day online replay will be available approximately one hour following the conclusion of the live broadcast. A live audio webcast can be accessed at https://events.q4inc.com/at
Lincoln, Nebraska, Sept. 06, 2023 (GLOBE NEWSWIRE) -- National Research Corporation, dba NRC Health, (NASDAQ:NRC) announced that its Board of Directors has declared a special dividend of one dollar ($1.00) per share to shareholders of record as of the close of business on Monday, September 18, 2023, and payable on Friday, September 22, 2023. For more than 40 years, NRC Health (NASDAQ:NRC) has led the charge to humanize healthcare and support organizations in their understanding of each unique individual. NRC Health's commitment to Human Understanding® helps leading healthcare systems get to know each person they serve not as point-in-time insights, but as an ongoing relationship. Guided
Lincoln, Nebraska, Aug. 21, 2023 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ:NRC) today announced that its Board of Directors has declared a quarterly cash dividend of $0.12 (twelve cents) per share payable Friday, October 13, 2023, to shareholders of record as of the close of business on Friday, September 29, 2023. For more than 40 years, NRC Health (NASDAQ:NRC) has led the charge to humanize healthcare and support organizations in their understanding of each unique individual. NRC Health's commitment to Human Understanding® helps leading healthcare systems get to know each person they serve not as point-in-time insights, but as an ongoing relati
Today, at NRC Health's 30th annual conference, Human Understanding Beyond | HUB24, the organization debuted healthcare's most comprehensive experience management platform and announced strategic acquisitions and partnerships to enable greater human connection across the healthcare journey. NRC Health, a recognized leader in delivering innovative solutions and data-driven insights to improve healthcare experiences, announced a new suite of next-gen AI-enabled products, along with an acquisition and new partnership, today at HUB24. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240822567645/en/Today, at NRC Health's 30th annual
National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the second quarter 2024 and several other corporate developments. Financial Results Revenue for the quarter was approximately $35 million compared with approximately $36 million in the 2023 quarter. Earnings per diluted share were $0.26 compared with $0.29 for the 2023 quarter. At June 30, 2024, the Company's net indebtedness (total borrowing minus cash and cash equivalents) was approximately $42 million. Total recurring contract value (TRCV) was approximately $138 million at June 30, 2024. Credit Agreement Amendment Effective August 5, 2024, the Company and its lender entered into a Third Amendm
National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the first quarter 2024. CEO Commentary Michael Hays, Chief Executive Officer, commented: "NRC continues to be strongly positioned for growth in our expanding markets. Our decades of benchmarks and trusted thought leadership afford healthcare insights unavailable to most competitors, while our client service remains unmatched, and we continue to roll out innovative new products and technologies. Our mission to enhance outcomes and experiences for everyone in the healthcare journey, while improving our clients' bottom lines, provides true alignment with our clients. "Healthcare systems are facing unp
National Research Corporation (NASDAQ:NRC) today announced that it will provide an online web simulcast of its 2024 first quarter earnings conference call on Wednesday, May 8, 2024. The Company's results for the 2024 first quarter will be released after the close of the market on Tuesday, May 7, 2024. The live broadcast of National Research Corporation's conference call will begin at 11:00 a.m. Eastern Time on May 8, 2024. A 30-day online replay will be available approximately one hour following the conclusion of the live broadcast. A live audio webcast can be accessed at https://events.q4inc.com/attendee/554254445. The webcast will also be available for replay. For more than 40 years
Baron will align and advance NRC Health's experience solutions platform to solve health care industry challenges and continue effectively innovating and supporting experience improvement for health systems across the nation. NRC Health, a recognized leader providing solutions and data driven insights for improving health care experiences, announced today the appointment of Jennifer Baron as the organization's first chief experience officer. Baron's addition is part of the organization's continued investments in leadership and innovation to align with the evolving healthcare landscape. This press release features multimedia. View the full release here: https://www.businesswire.com/news/ho
National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the fourth quarter 2023. CEO Commentary Michael Hays, Chief Executive Officer, commented: "We're pleased to start 2024 with momentum from another consecutive quarter of growth in new sales and operating margin. We have trimmed non-core service lines, and developed our capability across the patient, customer, and employee experience continuum to focus on our clients' most important needs. With industry-leading solutions – from C-Suite strategy through The Governance Institute, to customized data benchmarking and analysis, to actionable front-line solutions – NRC is better positioned than ever, and our
National Research Corporation (NASDAQ:NRC) today announced that it will provide an online web simulcast of its 2023 fourth quarter and year-end earnings conference call on Wednesday, February 14, 2024. The Company's results for the 2023 fourth quarter will be released after the close of the market on Tuesday, February 13, 2024. The live broadcast of National Research Corporation's conference call will begin at 11:00 a.m. Eastern Time on February 14, 2024. A 30-day online replay will be available approximately one hour following the conclusion of the live broadcast. A live audio webcast can be accessed at https://events.q4inc.com/attendee/823574505. The webcast will also be available for
NRC Health, the leading provider of human-centered healthcare solutions and data-driven insights, is elevating its leadership team with the appointment of four executive-officer positions. The strategic move will allow NRC Health to accelerate innovation while continuing to provide exceptional customer experiences to its partners. Four newly created executive leadership roles will guide NRC Health's strategy and success, including: Helen Hrdy, Chief Customer Officer Jason Hahn, Chief Revenue Officer Christophe Louvion, Chief Product Technology Officer Andy Monnich, Chief Corporate Development Officer "Strong leadership is key in driving innovation and meeting the ever-evolv
Yuma Regional Medical Center (YRMC) has selected NRC Health, a nationally-recognized leader in patient experience improvement, to be its partner in building Human Understanding® across its network through humanized healthcare solutions and data-driven insights to empower YRMC's primary value of "Patients Come First." A leading not-for-profit hospital, YRMC serves residents and visitors of Yuma, Arizona, and surrounding areas. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240131327622/en/ YRMC was drawn to NRC Health's human-centered approach to care. "It's the focus on those moments and that relational aspect of healthcare as
National Research Corporation, dba NRC Health, (NASDAQ:NRC) has announced the following appointments of four newly created executive officer positions: Helen Hrdy – Chief Customer Officer Jason Hahn – Chief Revenue Officer Christophe Louvion – Chief Product Technology Officer Andy Monnich – Chief Corporate Development Officer Helen Hrdy, a leader at NRC Health, has been promoted to the role of Chief Customer Officer significantly expanding her responsibilities. Jason Hahn, Christophe Louvion, and Andy Monnich have joined NRC Health with a track record of success in similar positions at leading healthcare information and technology companies such as Press Ganey, Perceptyx, Epi
Baron will align and advance NRC Health's experience solutions platform to solve health care industry challenges and continue effectively innovating and supporting experience improvement for health systems across the nation. NRC Health, a recognized leader providing solutions and data driven insights for improving health care experiences, announced today the appointment of Jennifer Baron as the organization's first chief experience officer. Baron's addition is part of the organization's continued investments in leadership and innovation to align with the evolving healthcare landscape. This press release features multimedia. View the full release here: https://www.businesswire.com/news/ho
NRC Health, the leading provider of human-centered healthcare solutions and data-driven insights, is elevating its leadership team with the appointment of four executive-officer positions. The strategic move will allow NRC Health to accelerate innovation while continuing to provide exceptional customer experiences to its partners. Four newly created executive leadership roles will guide NRC Health's strategy and success, including: Helen Hrdy, Chief Customer Officer Jason Hahn, Chief Revenue Officer Christophe Louvion, Chief Product Technology Officer Andy Monnich, Chief Corporate Development Officer "Strong leadership is key in driving innovation and meeting the ever-evolv
LINCOLN, Neb., May 19, 2022 (GLOBE NEWSWIRE) -- National Research Corporation, doing business as NRC Health ("NRC Health," "NRC", the "Company), the leading provider of in-depth customer insights in healthcare, today announced the appointment of Parul Bhandari to its Board of Directors, effective immediately. "Along with the rest of the Board, we are excited to share that Parul Bhandari has joined NRC Health as our newest Director," said NRC Health CEO Michael Hays. "Parul is an accomplished technology leader who brings a wealth of expertise on leveraging data and AI for positive impact to her new board role. Her experience driving industry solutions and engaging in digital transformati
10-Q - NATIONAL RESEARCH CORP (0000070487) (Filer)
8-K - NATIONAL RESEARCH CORP (0000070487) (Filer)
8-K - NATIONAL RESEARCH CORP (0000070487) (Filer)
10-Q - NATIONAL RESEARCH CORP (0000070487) (Filer)
8-K - NATIONAL RESEARCH CORP (0000070487) (Filer)
DEF 14A - NATIONAL RESEARCH CORP (0000070487) (Filer)
10-K - NATIONAL RESEARCH CORP (0000070487) (Filer)
8-K - NATIONAL RESEARCH CORP (0000070487) (Filer)
8-K - NATIONAL RESEARCH CORP (0000070487) (Filer)
8-K - NATIONAL RESEARCH CORP (0000070487) (Filer)
SC 13G/A - NATIONAL RESEARCH CORP (0000070487) (Subject)
SC 13D/A - NATIONAL RESEARCH CORP (0000070487) (Subject)
SC 13G/A - NATIONAL RESEARCH CORP (0000070487) (Subject)
SC 13D/A - NATIONAL RESEARCH CORP (0000070487) (Subject)
SC 13G/A - NATIONAL RESEARCH CORP (0000070487) (Subject)
SC 13D/A - NATIONAL RESEARCH CORP (0000070487) (Subject)
SC 13D/A - NATIONAL RESEARCH CORP (0000070487) (Subject)
SC 13G/A - NATIONAL RESEARCH CORP (0000070487) (Subject)
SC 13D/A - NATIONAL RESEARCH CORP (0000070487) (Subject)
SC 13D - NATIONAL RESEARCH CORP (0000070487) (Subject)
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro. Here's the latest list of major oversold players in this sector, having an RSI near or below 30. Cassava Sciences Inc (NASDAQ:SAVA) On July 1, Cassava Sciences engaged the U.S. Department of Justice (DOJ) and the U.S. Secu
National Research (NASDAQ:NRC) reported quarterly earnings of $0.27 per share. This is a 3.57 percent decrease over earnings of $0.28 per share from the same period last year. The company reported $35.31 million in sales this quarter. This is a 3.18 percent decrease over sales of $36.47 million the same period last year.
National Research (NASDAQ:NRC) reported quarterly earnings of $0.36 per share. This is a 33.33 percent increase over earnings of $0.27 per share from the same period last year. The company reported $38.00 million in sales this quarter. This is a 0.37 percent decrease over sales of $38.14 million the same period last year.
Companies Reporting Before The Bell • LCI Indus (NYSE:LCII) is likely to report quarterly earnings at $0.18 per share on revenue of $838.27 million. • Navios Maritime Partners (NYSE:NMM) is projected to report quarterly earnings at $2.62 per share on revenue of $334.79 million. • Restaurant Brands Intl (NYSE:QSR) is estimated to report quarterly earnings at $0.74 per share on revenue of $1.81 billion. • OrganiGram Holdings (NASDAQ:OGI) is projected to report quarterly loss at $0.13 per share on revenue of $37.77 million. • Hyatt Hotels (NYSE:H) is projected to report quarterly earnings at $0.29 per share on revenue of $1.86 billion. • InMode (NASDAQ:INMD) is likely to report quarterly
National Research (NASDAQ:NRC) reported quarterly earnings of $0.32 per share. This is a 3.03 percent decrease over earnings of $0.33 per share from the same period last year. The company reported $37.95 million in sales this quarter. This is a 0.67 percent increase over sales of $37.69 million the same period last year.
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter. • Ballard Power Systems (NASDAQ:BLDP) is expected to report quarterly loss at $0.13 per share on revenue of $26.20 million. • Melco Resorts and Enter (NASDAQ:MLCO) is likely to report quarterly earnings at $0.03 per share on revenue of $1.03 billion. • Consolidated Comms Hldgs (NASDAQ:CNSL) is expected to report quarterly loss at $0.37 per share on revenue of $274.23 million. • Sophia Genetics (NASDAQ:SOPH) is projected to report quarterly loss at $0.31 per share on revenue of $15.63 million. • Endeavor Gr Hldgs (NYSE:EDR) is estimated to report quarterly earnings
The special dividend is declared to shareholders of record as of the close of business on Monday, September 18, 2023, and payable on Friday, September 22. 2023.
National Research (NASDAQ:NRC) reported quarterly earnings of $0.29 per share. This is a 12.12 percent decrease over earnings of $0.33 per share from the same period last year. The company reported $36.16 million in sales this quarter. This is a 3.03 percent decrease over sales of $37.29 million the same period last year.
Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is estimated to report earnings for its first quarter. • BP (NYSE:BP) is projected to report quarterly earnings at $1.21 per share on revenue of $54.48 billion. • HSBC Holdings (NYSE:HSBC) is projected to report earnings for its second quarter. • AudioCodes (NASDAQ:AUDC) is projected to report quarterly earnings at $0.10 per share on revenue of $60.38 million. • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterly loss at $0.24 per share on revenue of $16.37 million. • Enterprise Prods Partners (NYSE:EPD) is estimated to report quarterly earnings at $0.59 per share on revenue of $13.03 billion. • Landsea Homes (NAS
National Research (NASDAQ:NRC) reported quarterly earnings of $0.28 per share. This is a 17.65 percent decrease over earnings of $0.34 per share from the same period last year. The company reported $36.47 million in sales this quarter. This is a 5.12 percent decrease over sales of $38.44 million the same period last year.